Jazz Pharmaceuticals's total assets for Q3 2025 were $11.36B, an increase of 3.77% from the previous quarter. JAZZ total liabilities were $7.40B for the fiscal quarter, a 2.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.